Wikidata

(Q63571469)

English

A Single-Arm, Open-Label, Multicenter Clinical Trial With Nivolumab (BMS-936558) for Subjects With Histologically Confirmed Stage III (Unresectable) or Stage IV Melanoma Progressing Post Prior Treatment Containing an Anti-CTLA4 Monoclonal Antibo

clinical trial

In more languages

Statements

title
A Single-Arm, Open-Label, Multicenter Clinical Trial With Nivolumab (BMS-936558) for Subjects With Histologically Confirmed Stage III (Unresectable) or Stage IV Melanoma Progressing Post Prior Treatment Containing an Anti-CTLA4 Monoclonal Antibody (English)
0 references
country
Austria
0 references
Belgium
0 references
Finland
0 references
Germany
0 references
Greece
0 references
Hungary
0 references
Republic of Ireland
0 references
Italy
0 references
Luxembourg
0 references
Netherlands
0 references
Norway
0 references
Poland
0 references
Portugal
0 references
Romania
0 references
Spain
0 references
Sweden
0 references
Switzerland
0 references
United Kingdom
0 references
start time
7 October 2014
0 references
end time
18 January 2019
0 references
number of participants
1,215
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q63571469&oldid=2140179329"